YOU MATTER.
Upcoming Events
Kidney Cancer Association 2018 Patient Meeting
September 22 - September 23Seventeenth International Kidney Cancer Symposium
November 2 - November 3Charlotte Kidney Cancer Support Group – Holiday Luncheon
November 26 @ 1:00 pm - 3:30 pm
Publications
0
%
5-Year Survival Rate Percentage increase from 2007 through 2013
0
Estimated new cases in the US, this year
0
Estimated Deaths in the US, this year
0
People are living with kidney and renal pelvis cancer, according to NCI SEER data from 2014
Evaluate your treatment options and make decisions
From the Pressroom
News from Kidney Cancer Association This feed has been created by Kidney Cancer Association
-
More Frequent Use of Partial Nephrectomy May...
on June 13, 2018 at 5:21 pm
To evaluate trends in the use of partial nephrectomy in the United States, researchers collected information about more than 48,000 patients with non-metastatic kidney cancer treated between 1998 and 2007.06/13/2018 […]
-
Pembrolizumab Showed Overall Response Rate of...
on June 13, 2018 at 5:18 pm
KEYNOTE-427 is a single-arm, open-label, non-randomized, multi-cohort, Phase 2 study evaluating the safety and efficacy of KEYTRUDA as monotherapy in patients with advanced RCC who have not received prior systemic therapy.06/13/2018 […]
-
California emergency room use has actually risen...
on June 13, 2018 at 5:15 pm
Emergency department visits, including those that resulted in hospital admissions, grew an average 4 percent every year from 2010 to 2016.06/13/2018 […]
YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.
Kidney Cancer Association
The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers.
Kidney Cancer: Considering First-Line Treatment Options
Sandy Liu, MD, provides an overview of nonsurgical therapeutic options that have become available to treat renal cell carcinoma, or kidney cancer, in the first-line setting.
curetoday.com
12 hours ago
Visit https://t.co/VjybNt7LQQ to take a quiz that raises funds for research. https://t.co/wrBEEzg6oE
Visit https://t.co/VjybNt7LQQ to take a quiz that raises funds for research. https://t.co/wrBEEzg6oE
Visit https://t.co/VjybNt7LQQ to take a quiz that raises funds for research. pic.twitter.com/wrBEEzg6oE
— Kidney Cancer (@KidneyCancer) June 21, 2018
12 hours ago
Take this quiz about #KidneyCancer to support the research of talented young investigators. It costs you NOTHING. Take the quiz to save lives. https://t.co/uHdd9XTjbX
Take this quiz about #KidneyCancer to support the research of talented young investigators. It costs you NOTHING. Take the quiz to save lives. https://t.co/uHdd9XTjbX
13 hours ago
In this video, Sandy Liu, MD, provides an overview of nonsurgical therapeutic options that have become available to treat renal cell carcinoma, or kidney cancer, in the first-line setting. https://t.co/fsy9bEbvzL
In this video, Sandy Liu, MD, provides an overview of nonsurgical therapeutic options that have become available to treat renal cell carcinoma, or kidney cancer, in the first-line setting. https://t.co/fsy9bEbvzL
In this video, Sandy Liu, MD, provides an overview of nonsurgical therapeutic options that have become available to treat renal cell carcinoma, or kidney cancer, in the first-line setting. https://t.co/fsy9bEbvzL
— Kidney Cancer (@KidneyCancer) June 21, 2018